logo

For the Inventor, By the Inventor

Harrisburg, PA, United States of America

Neil D Christensen

USPTO Granted Patents = 11 

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 90(Granted Patents)


Company Filing History:

goldMedal10 out of 1,307 
 
The Penn State Research Foundation
 patents
silverMedal3 out of 404 
 
Virginia Commonwealth University
 patents
bronzeMedal1 out of 833,002 
Other
 patents
where one patent can have more than one assignee

Years Active: 2003-2020

Loading Chart...
11 patents (USPTO):Explore Patents
1. 10723790 - Method for diagnosis of polycystic ovary syndrome (PCOS) by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2) (2020-07-28),
2. 10183991 - Antibodies that recognize a DENN/MADD-domain-containing 1A variant 2 (DENND1A variant 2) (2019-01-22),
3. 10077309 - Compositions and methods for targeting of the surfactant protein A receptor (2018-09-18),
4. 9676844 - Pharmaceutical compositions comprising DENND1A variant 2 and methods of use thereof (2017-06-13),
5. 8821872 - Identification and characterization of a specific CCK-C receptor antibody for human pancreatic cancer and its use for early detection and staging of pancreatic cancer (2014-09-02),
6. 8435534 - Cancer immunotherapy (2013-05-07),
7. 7960361 - Nucleic acid cancer immunotherapy (2011-06-14),
8. 7704965 - Methods and materials for treating human papillomavirus infections (2010-04-27),
9. 7338929 - Cancer immunotherapy (2008-03-04),
10. 7183053 - Methods for detecting papillomavirus DNA in blood plasma and serum (2007-02-27),
11. 6511805 - Methods for detecting papillomavirus DNA in blood plasma and serum (2003-01-28),

Title: Neil D Christensen: Innovator in Medical Diagnostics

Introduction

Neil D Christensen is a prominent inventor based in Harrisburg, PA (US). He has made significant contributions to the field of medical diagnostics, particularly in relation to polycystic ovary syndrome (PCOS). With a total of 11 patents to his name, Christensen's work has the potential to impact many lives.

Latest Patents

One of Christensen's latest patents focuses on a method for diagnosing polycystic ovary syndrome by measuring levels of DENN/MADD domain containing 1A variant 2 (DENND1A variant 2). This patent provides pharmaceutical compositions and methods for treating DENND1A.V2 related disorders, including PCOS. Specifically, it details humanized and mouse monoclonal antibodies that are specific for DENND1A.V2, along with methods for their application.

Career Highlights

Throughout his career, Neil D Christensen has worked with notable institutions such as the Penn State Research Foundation and Virginia Commonwealth University. His innovative research has garnered attention and respect within the scientific community.

Collaborations

Christensen has collaborated with esteemed colleagues, including Waldemar Debinski and Akiva Mintz. These partnerships have furthered his research and contributed to the advancement of medical diagnostics.

Conclusion

Neil D Christensen's work in the field of medical diagnostics, particularly regarding PCOS, showcases his dedication to innovation and improving healthcare outcomes. His numerous patents reflect his commitment to advancing medical science and technology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…